BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 24294381)

  • 1. Clear cell papillary renal cell carcinoma: a clinicopathological study emphasizing ultrastructural features and cytogenetic heterogeneity.
    Shi SS; Shen Q; Xia QY; Tu P; Shi QL; Zhou XJ; Rao Q
    Int J Clin Exp Pathol; 2013; 6(12):2936-42. PubMed ID: 24294381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clear cell papillary renal cell carcinoma-like tumors in patients with von Hippel-Lindau disease are unrelated to sporadic clear cell papillary renal cell carcinoma.
    Williamson SR; Zhang S; Eble JN; Grignon DJ; Martignoni G; Brunelli M; Wang M; Gobbo S; Baldridge LA; Cheng L
    Am J Surg Pathol; 2013 Aug; 37(8):1131-9. PubMed ID: 23648463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicopathologic features of clear cell papillary renal cell carcinoma].
    Rao Q; Shen Q; Shi S; Xia Q; Lu Z; Yu B; Zhang R; He Y; Wang X; Ma H; Zhou X
    Zhonghua Bing Li Xue Za Zhi; 2014 Nov; 43(11):728-31. PubMed ID: 25582249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins.
    Rohan SM; Xiao Y; Liang Y; Dudas ME; Al-Ahmadie HA; Fine SW; Gopalan A; Reuter VE; Rosenblum MK; Russo P; Tickoo SK
    Mod Pathol; 2011 Sep; 24(9):1207-20. PubMed ID: 21602815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal Cell Carcinoma with Clear Cell Papillary Features: Perspectives of a Differential Diagnosis.
    Somorácz Á; Kuthi L; Micsik T; Jenei A; Hajdu A; Vrabély B; Rásó E; Sápi Z; Bajory Z; Kulka J; Iványi B
    Pathol Oncol Res; 2020 Jul; 26(3):1767-1776. PubMed ID: 31656019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney.
    Aydin H; Chen L; Cheng L; Vaziri S; He H; Ganapathi R; Delahunt B; Magi-Galluzzi C; Zhou M
    Am J Surg Pathol; 2010 Nov; 34(11):1608-21. PubMed ID: 20924276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clear cell and papillary renal cell carcinomas in hereditary papillary renal cell carcinoma (HPRCC) syndrome: a case report.
    Ferlicot S; Just PA; Compérat E; Rouleau E; Tissier F; Vaessen C; Richard S
    Diagn Pathol; 2021 Nov; 16(1):107. PubMed ID: 34801057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do Clear Cell Papillary Renal Cell Carcinomas Have Malignant Potential?
    Diolombi ML; Cheng L; Argani P; Epstein JI
    Am J Surg Pathol; 2015 Dec; 39(12):1621-34. PubMed ID: 26426379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VHL mutations and dysregulation of pVHL- and PTEN-controlled pathways in multilocular cystic renal cell carcinoma.
    von Teichman A; Compérat E; Behnke S; Storz M; Moch H; Schraml P
    Mod Pathol; 2011 Apr; 24(4):571-8. PubMed ID: 21151099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GATA3 as a valuable marker to distinguish clear cell papillary renal cell carcinomas from morphologic mimics.
    Mantilla JG; Antic T; Tretiakova M
    Hum Pathol; 2017 Aug; 66():152-158. PubMed ID: 28705707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implication of VHL, ERK5, and HIF-1alpha in clear cell renal cell carcinoma: Molecular basis.
    Serrano-Oviedo L; Giménez-Bachs JM; Nam-Cha SY; Cimas FJ; García-Cano J; Sánchez-Prieto R; Salinas-Sánchez AS
    Urol Oncol; 2017 Mar; 35(3):114.e15-114.e22. PubMed ID: 27836247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VHL-gene deletion in single renal tubular epithelial cells and renal tubular cysts: further evidence for a cyst-dependent progression pathway of clear cell renal carcinoma in von Hippel-Lindau disease.
    Montani M; Heinimann K; von Teichman A; Rudolph T; Perren A; Moch H
    Am J Surg Pathol; 2010 Jun; 34(6):806-15. PubMed ID: 20431476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic endocrine microadenomatosis in patients with von Hippel-Lindau disease: characterization by VHL/HIF pathway proteins expression.
    Périgny M; Hammel P; Corcos O; Larochelle O; Giraud S; Richard S; Sauvanet A; Belghiti J; Ruszniewski P; Bedossa P; Couvelard A
    Am J Surg Pathol; 2009 May; 33(5):739-48. PubMed ID: 19238077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VHL and HIF-1α: gene variations and prognosis in early-stage clear cell renal cell carcinoma.
    Lessi F; Mazzanti CM; Tomei S; Di Cristofano C; Minervini A; Menicagli M; Apollo A; Masieri L; Collecchi P; Minervini R; Carini M; Bevilacqua G
    Med Oncol; 2014 Mar; 31(3):840. PubMed ID: 24446253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal cell carcinoma with leiomyomatous stroma--further immunohistochemical and molecular genetic characteristics of unusual entity.
    Peckova K; Grossmann P; Bulimbasic S; Sperga M; Perez Montiel D; Daum O; Rotterova P; Kokoskova B; Vesela P; Pivovarcikova K; Bauleth K; Branzovsky J; Dubova M; Hora M; Michal M; Hes O
    Ann Diagn Pathol; 2014 Oct; 18(5):291-6. PubMed ID: 25175809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clear cell papillary renal cell carcinoma and renal angiomyoadenomatous tumor: two variants of a morphologic, immunohistochemical, and genetic distinct entity of renal cell carcinoma.
    Deml KF; Schildhaus HU; Compérat E; von Teichman A; Storz M; Schraml P; Bonventre JV; Fend F; Fleige B; Nerlich A; Gabbert HE; GaBler N; Grobholz R; Hailemariam S; Hinze R; Knüchel R; Lhermitte B; Nesi G; Rüdiger T; Sauter G; Moch H
    Am J Surg Pathol; 2015 Jul; 39(7):889-901. PubMed ID: 25970683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clear cell papillary renal cell carcinoma in patients with von Hippel-Lindau syndrome--clinicopathological features and comparative genomic analysis of 3 cases.
    Rao P; Monzon F; Jonasch E; Matin SF; Tamboli P
    Hum Pathol; 2014 Sep; 45(9):1966-72. PubMed ID: 25081542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analyses of potential predictive markers and survival data for a response to sunitinib in patients with metastatic renal cell carcinoma.
    Dornbusch J; Zacharis A; Meinhardt M; Erdmann K; Wolff I; Froehner M; Wirth MP; Zastrow S; Fuessel S
    PLoS One; 2013; 8(9):e76386. PubMed ID: 24086736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clear cell papillary renal cell carcinoma with angiomyomatous stroma: a histological, immunohistochemical, and fluorescence in situ hybridization study.
    Alexiev BA; Thomas C; Zou YS
    Virchows Arch; 2014 Jun; 464(6):709-16. PubMed ID: 24771120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.